Table 4:

Number, percent, and 95% confidence intervals of specific cancer by stage at diagnosis by urban, large rural, and small rural Oklahoma settings 2016–2020

	Urban			Large Rural			Small Rural
	Cancers	% State Cancers	95% CI	Cancers	% State Cancers	95% CI	Cancers	% State Cancers	95% CI
Female Breast
In Situ	1657	14.4%	13.5–15.3	477	12.0%	10.6–13.4	181	12.4%	10.0–14.8
Localized	6124	53.2%	51.3–55.1	2116	53.4%	50.1–56.7	732	50.3%	44.8–55.8
Regional	2662	23.1%	19.9–26.3	891	22.5%	17.1–27.9	314	21.6%	13.3–29.9
Distant	660	5.7%	3.4–8.0	226	5.7%	2.8–8.6	95	6.5%	2.3–10.7
Unknown *	404	4.1%	3.7–4.5	249	6.3%	5.5–7.1	132	9.1%	7.6–10.6
Cervix
Localized	228	37.4%	33.3–41.5	101	38.3%	32.0–44.6	28	31.8%	20.7–42.9
Regional	208	34.2%	30.1–38.3	92	34.8%	28.6–41.0	30	34.1%	22.9–45.3
Distant	110	18.1%	14.7–21.5	46	17.4%	12.4–22.4	16	18.2%	8.8–27.6
Unknown	63	10.3%	7.9–12.7	25	9.5%	6.0–13.0	14	15.9%	8.3–23.5
Colorectal
In Situ	113	2.0%	1.6–2.4	67	2.6%	1.9–3.3	16	1.4%	0.6–2.2
Localized *	1846	33.1%	31.8–34.4	737	28.4%	26.5–30.3	332	29.6%	26.5–32.7
Regional	1870	33.5%	32.2–34.8	904	34.9%	32.9–36.9	367	32.7%	29.5–35.9
Distant	1215	21.8%	20.6–23.0	542	20.9%	19.1–22.7	212	18.9%	16.2–21.6
Unknown	537	9.6%	8.8–10.4	342	13.2%	11.9–14.5	194	17.3%	15.1–19.5
Lung
In Situ	16	0.2%	0.1–0.3
Localized *	2150	23.6%	22.6–24.6	969	21.3%	19.9–22.7	341	19.8%	17.5–22.1
Regional	1886	20.7%	19.8–21.6	966	21.2%	19.8–22.6	334	19.4%	17.1–21.7
Distant	4021	44.2%	43.1–45.3	1891	41.5%	39.9–43.1	713	41.4%	38.8–44.0
Unknown	1026	11.3%	10.7–11.9	732	16.1%	15.0–17.2	333	19.3%	17.4–21.2
Prostate
In Situ	Suppressed			Suppressed			Suppressed
Localized *	5506	70.0%	69.0–71.0	1624	60.9%	59.1–62.7	697	59.4%	56.6–62.2
Regional	857	10.9%	10.1–11.7	312	11.7%	10.2–13.2	134	11.4%	9.1–13.7
Distant *	577	7.3%	6.7–7.9	241	9.0%	7.7–10.3	83	7.1%	5.2–9.0
Unknown	924	11.7%	11.0–12.4	489	18.3%	16.8–19.8	260	22.1%	19.7–24.5

^*statistically significant difference;